Metraipolis › archive › dc_333fdc43ae72

Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumors — Europe PMC PMID:41390817

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41390817
DOI
10.1038/s41419-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-07T16:15:17.257Z
SHA-256 of the archived text
754f49b2d9ebb0a0e3943c61833a2c16162fc898e0ed617022577ff5337c876f
Stable URL of this page
https://metraipolis.com/documento/dc_333fdc43ae72

How to cite

Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumors — Europe PMC PMID:41390817 — Europe PMC (en), https://europepmc.org/article/MED/41390817 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_333fdc43ae72 (Metraipolis archive dc_333fdc43ae72, sha256 754f49b2d9ebb0a0e3943c61833a2c16162fc898e0ed617022577ff5337c876f)
BibTeX
@misc{dc333fdc43ae72,
  title = {Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumors — Europe PMC PMID:41390817},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41390817},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_333fdc43ae72; sha256 754f49b2d9ebb0a0e3943c61833a2c16162fc898e0ed617022577ff5337c876f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41390817. Agents can read the archived copy with the MCP tool read_document.